Hong Mei Pharmaceutical Co., Ltd. (hereinafter referred to as" Health America Pharmaceutical ") was established in 1997, is a Chinese Herbal Medicine, Chemistry bulk drugs and formulations production-oriented set of pharmaceutical manufacturing, R & D and pharmaceutical, medical device marketing in the modern large-scale pharmaceutical enterprises, state-level key high-tech enterprises. March 2001 Health America Pharmaceutical A shares listed in Shanghai Stock Exchange, stock code: 600 518; company's existing share capital of 169,437 total shares and total assets of $ 7.1 billion in net assets of more than 4.5 billion yuan. 2009 Health America Pharmaceutical revenues more than 2.3 billion yuan achieved, profits and taxes 600 million yuan. Health America Pharmaceutical chemistry medicine has passed GMP, medicine GMP, GSP certification, and ISO14001, ISO9001 and GB \\ T28001 management system certification.
Health America Pharmaceutical chemicals with a production base, 2 Pieces of Chinese medicine production base of high-tech industrialization demonstration, a Chinese Herbal Medicine logistics and distribution center, a provincial enterprise technology center, a post-doctoral research station; a total investment of more than 10 million Chinese logistics distribution center and general hospital with Chinese characteristics, the construction project is under construction. Health America Pharmaceutical products currently includes four state-level new drugs, including 20 kinds of chemicals and bulk drugs, more than 1,000 kinds of Chinese Herbal Medicine, more than 12,000 product regulation. U.S. Pharmaceutical and Health Research Institute of Chinese Medicine, Guangzhou University of Chinese Medicine and other medical research institutions in the country closely, the formation of the CPC Central Committee, member of Education, Science and Sports Committee of the CPPCC, vice director of the China Soong Ching Ling Foundation, Vice Chairman Zhang Wenkang, Chinese Academy of Sciences Chen Ji, Chinese Academy of Engineering Wang YY, Shi Xuemin, Liu Geng Tao, and many medical community authority and medical dean as a consultant for the company team of experts to form a strong external technical support team, for the production and product development provides a strong technical support. Health America Pharmaceutical, "doxazosin mesylate project", "Chinese Herbal Medicine industrialization demonstration project" has been listed as a national high-tech industrial technology construction projects, national "Eleventh Five-Year Plan" project.
the future, Hong Mei medicine will be based medicine, in Chinese Herbal Medicine to further clarify and strengthen the core competitiveness of industry and ensure that its doing good, and stronger at the same time, through strategic restructuring and strategic investment, industry and other forms of resource integration, active investment and development of medical treatment, pharmaceutical logistics, supply of raw herbs, medicinal extracts and ingredients such as Chinese medicine and Edible Products upstream and downstream industries, the Hong Mei eventually become a strong comprehensive strength and competitiveness of the pharmaceutical resource-based enterprises.
